Cardiologists' Perspectives on Race-Based Drug Labels and Prescribing Within the Context of Treating Heart Failure

Health Equity - United States
doi 10.1089/heq.2018.0074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

3 Advances in Treating Heart Failure

Postgraduate Medical Journal
Medicine
2019English

Drug Treatment of Heart Failure

Drugs
Pharmacology
1990English

Influence of Age, Gender, and Race on Depression in Heart Failure Patients

Journal of the American College of Cardiology
Cardiovascular MedicineCardiology
2004English

Consultation With Cardiologists for Persons With New-Onset Chronic Heart Failure: A Population-Based Study

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2009English

Advanced Heart Failure: Trans-Atlantic Perspectives on the Heart Failure Association of the European Society of Cardiology Position Statement

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Correction To: Cardiologists’ Perception of Wearable Device Data in Patients With Heart Failure

Journal of General Internal Medicine
Internal Medicine
2020English

Machine Learning-Based Identification and Rule-Based Normalization of Adverse Drug Reactions in Drug Labels

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2019English

Potential Drug-Drug Interactions in Heart Failure Patients

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2019English

Racial and Ethnic Disparities in Care: The Perspectives of Cardiologists

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy